Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies.
Fausto PetrelliChiara LazzariRaffaele ArditoKaren BorgonovoAlessandra BulottaBarbara ContiMary CabidduJody Filippo CapitanioMatteo BrighentiMara GhilardiLuca GianniSandro BarniVanesa GregorcPublished in: PloS one (2018)
Based on these data, ALK inhibitors are effective in both naive and pre-treated patients with similar IC ORR and IC DCR, irrespective of the line of therapy.